Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Temporary equity, beginning balance (in shares) at Jan. 31, 2020	[1]	160,583,203
Temporary equity, beginning balance at Jan. 31, 2020		$ 520,241,000
Temporary equity, ending balance (in shares) at Apr. 30, 2020	[1]	160,583,203
Temporary equity, ending balance at Apr. 30, 2020		$ 520,241,000
Beginning balance (in shares) at Jan. 31, 2020	[1]		11,918,418
Beginning balance at Jan. 31, 2020		(462,021,000)	$ 1,000	$ 20,331,000	$ 37,000	$ (482,390,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		1,071,203
Issuance of common stock upon exercise of vested stock options		436,000		436,000
Vesting of early exercised stock options		10,000		10,000
Stock-based compensation		910,000		910,000
Net loss		(30,098,000)				(30,098,000)
Other comprehensive income (loss)		(56,000)			(56,000)
Ending balance (in shares) at Apr. 30, 2020	[1]		12,989,621
Ending balance at Apr. 30, 2020		$ (490,819,000)	$ 1,000	21,687,000	(19,000)	(512,488,000)
Temporary equity, beginning balance (in shares) at Jan. 31, 2020	[1]	160,583,203
Temporary equity, beginning balance at Jan. 31, 2020		$ 520,241,000
Temporary equity, ending balance (in shares) at Oct. 31, 2020	[1]	182,934,257
Temporary equity, ending balance at Oct. 31, 2020		$ 615,755,000
Beginning balance (in shares) at Jan. 31, 2020	[1]		11,918,418
Beginning balance at Jan. 31, 2020		(462,021,000)	$ 1,000	20,331,000	37,000	(482,390,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustment		14,000
Net loss		(106,275,000)
Other comprehensive income (loss)		(9,000)
Ending balance (in shares) at Oct. 31, 2020	[1]		15,854,300
Ending balance at Oct. 31, 2020		$ (531,017,000)	$ 2,000	57,618,000	28,000	(588,665,000)
Temporary equity, beginning balance (in shares) at Apr. 30, 2020	[1]	160,583,203
Temporary equity, beginning balance at Apr. 30, 2020		$ 520,241,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)	[1]	21,783,334
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs		$ 92,433,000
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock		(58,625,000)
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		$ 58,625,000
Temporary equity, ending balance (in shares) at Jul. 31, 2020	[1]	182,366,537
Temporary equity, ending balance at Jul. 31, 2020		$ 612,674,000
Beginning balance (in shares) at Apr. 30, 2020	[1]		12,989,621
Beginning balance at Apr. 30, 2020		(490,819,000)	$ 1,000	21,687,000	(19,000)	(512,488,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization		31,390,000		31,390,000
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock		58,625,000		58,625,000
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		58,625,000		58,625,000
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		1,523,641
Issuance of common stock upon exercise of vested stock options		1,095,000		1,095,000
Issuance of common stock related to early exercise of stock options (in shares)	[1]		66,440
Vesting of early exercised stock options		1,000		1,000
Stock-based compensation		1,190,000		1,190,000
Net loss		(35,287,000)				(35,287,000)
Other comprehensive income (loss)		69,000			69,000
Ending balance (in shares) at Jul. 31, 2020	[1]		14,579,702
Ending balance at Jul. 31, 2020		$ (492,361,000)	$ 1,000	55,363,000	50,000	(547,775,000)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)	[1]	567,720
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs		$ 3,081,000
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock		1,752,000
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		$ 1,752,000
Temporary equity, ending balance (in shares) at Oct. 31, 2020	[1]	182,934,257
Temporary equity, ending balance at Oct. 31, 2020		$ 615,755,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization		155,000		155,000
Beneficial conversion feature Series H-1 preferred warrants		1,752,000		1,752,000
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		(1,752,000)		(1,752,000)
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		1,240,498
Issuance of common stock upon exercise of vested stock options		890,000	$ 1,000	889,000
Issuance of common stock related to early exercise of stock options (in shares)	[1]		34,100
Vesting of early exercised stock options		4,000		4,000
Stock-based compensation		1,207,000		1,207,000
Foreign currency translation adjustment		(22,000)			(22,000)
Net loss		(40,890,000)
Other comprehensive income (loss)		(22,000)
Ending balance (in shares) at Oct. 31, 2020	[1]		15,854,300
Ending balance at Oct. 31, 2020		$ (531,017,000)	$ 2,000	57,618,000	28,000	(588,665,000)
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	[1]	182,934,257
Temporary equity, beginning balance at Jan. 31, 2021		$ 615,697,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	[1]	(182,934,257)
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend		$ (615,697,000)
Temporary equity, ending balance (in shares) at Apr. 30, 2021	[1]	0
Temporary equity, ending balance at Apr. 30, 2021		$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]		22,961,032
Beginning balance at Jan. 31, 2021		(616,521,000)	$ 2,000	62,736,000	155,000	(679,414,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	[1]		194,060,336
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend		615,697,000	$ 20,000	615,677,000
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization		66,606,000		66,606,000
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)	[1]		60,746,989
Issuance of common stock upon the reverse recapitalization, net of issuance costs		200,466,000	$ 6,000	200,460,000
Issuance of common stock upon exercise of warrants (in shares)	[1]		9,766,774
Issuance of common stock upon exercise of warrants		225,376,000	$ 1,000	225,375,000
Contingent earnout liability recognized upon the closing of the reverse recapitalization		(828,180,000)		(828,180,000)
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)	[1]		17,539,657
Issuance of earnout shares upon triggering events, net of tax withholding		488,305,000	$ 2,000	488,303,000
Reclassification of remaining contingent earnout liability upon triggering event		242,640,000		242,640,000
Vesting of early exercised stock options		78,000		78,000
Repurchase of early exercised common stock (in shares)	[1]		(1,588)
Stock-based compensation		7,577,000		7,577,000
Net loss		82,289,000				82,289,000
Other comprehensive income (loss)		7,000			7,000
Ending balance (in shares) at Apr. 30, 2021	[1]		305,073,200
Ending balance at Apr. 30, 2021		$ 484,340,000	$ 31,000	1,081,272,000	162,000	(597,125,000)
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	[1]	182,934,257
Temporary equity, beginning balance at Jan. 31, 2021		$ 615,697,000
Temporary equity, ending balance (in shares) at Oct. 31, 2021	[1]	0
Temporary equity, ending balance at Oct. 31, 2021		$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]		22,961,032
Beginning balance at Jan. 31, 2021		$ (616,521,000)	$ 2,000	62,736,000	155,000	(679,414,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of vested stock options (in shares)		4,666,083
Foreign currency translation adjustment		$ (531,000)
Net loss		(72,092,000)
Other comprehensive income (loss)		(531,000)
Ending balance (in shares) at Oct. 31, 2021	[1]		330,987,173
Ending balance at Oct. 31, 2021		$ 585,399,000	$ 33,000	1,337,247,000	(376,000)	(751,505,000)
Temporary equity, beginning balance (in shares) at Apr. 30, 2021	[1]	0
Temporary equity, beginning balance at Apr. 30, 2021		$ 0
Temporary equity, ending balance (in shares) at Jul. 31, 2021	[1]	0
Temporary equity, ending balance at Jul. 31, 2021		$ 0
Beginning balance (in shares) at Apr. 30, 2021	[1]		305,073,200
Beginning balance at Apr. 30, 2021		484,340,000	$ 31,000	1,081,272,000	162,000	(597,125,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)	[1]		652,901
Issuance of common stock upon exercise of warrants (in shares)	[1]		4,378,568
Issuance of common stock upon exercise of warrants		113,608,000		113,608,000
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)	[1]		8,773,596
Issuance of earnout shares upon triggering events, net of tax withholding		(8,080,000)	$ 1,000	(8,081,000)
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		3,292,219
Issuance of common stock upon exercise of vested stock options		1,761,000		1,761,000
Vesting of early exercised stock options		40,000		40,000
Stock-based compensation		28,293,000		28,293,000
Net loss		(84,938,000)				(84,938,000)
Other comprehensive income (loss)		(12,000)
Ending balance (in shares) at Jul. 31, 2021	[1]		322,170,484
Ending balance at Jul. 31, 2021		$ 535,012,000	$ 32,000	1,216,893,000	150,000	(682,063,000)
Temporary equity, ending balance (in shares) at Oct. 31, 2021	[1]	0
Temporary equity, ending balance at Oct. 31, 2021		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)	[1]		1,741,713
Issuance of common stock under stock plans, net of tax withholding		976,000		976,000
Issuance of common stock upon exercise of warrants (in shares)	[1]		1,379,800
Issuance of common stock upon exercise of warrants		1,264,000		1,264,000
Issuance of common stock in connection with acquisitions (in shares)	[1]		5,695,176
Issuance of common stock in connection with acquisitions		102,058,000	$ 1,000	102,057,000
Vesting of early exercised stock options		35,000		35,000
Stock-based compensation		16,022,000		16,022,000
Foreign currency translation adjustment		(526,000)
Net loss		(69,442,000)
Other comprehensive income (loss)		(526,000)			(526,000)
Ending balance (in shares) at Oct. 31, 2021	[1]		330,987,173
Ending balance at Oct. 31, 2021		$ 585,399,000	$ 33,000	$ 1,337,247,000	$ (376,000)	$ (751,505,000)

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3.